메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Lin Kun-Mo (Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan) Su Ching-Chun (Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan) Chen Jui-Yi (Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan) Pan Szu-Yu (Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan) Chuang Min-Hsiang (Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan) Lin Cheng-Jui (Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan) Wu Chih-Jen (Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan) Pan Heng-Chih (Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan) Wu Vin-Cent (Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan)
저널정보
대한신장학회 Kidney Research and Clinical Practice Kidney Research and Clinical Practice Vol.43 No.4
발행연도
2024.7
수록면
393 - 405 (13page)
DOI
10.23876/j.krcp.23.284

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Traditional acute kidney injury (AKI) classifications, which are centered around semi-anatomical lines, can no longer capture the complexity of AKI. By employing strategies to identify predictive and prognostic enrichment targets, experts could gain a deeper comprehension of AKI’s pathophysiology, allowing for the development of treatment-specific targets and enhancing individualized care. Subphenotyping, which is enriched with AKI biomarkers, holds insights into distinct risk profiles and tailored treatment strategies that redefine AKI and contribute to improved clinical management. The utilization of biomarkers such as N-acetyl-β-D-glucosaminidase, tissue inhibitor of metalloprotease-2·insulin-like growth factor-binding protein 7, kidney injury molecule-1, and liver fatty acid-binding protein garnered significant attention as a means to predict subclinical AKI. Novel biomarkers offer promise in predicting persistent AKI, with urinary motif chemokine ligand 14 displaying significant sensitivity and specificity. Furthermore, they serve as predictive markers for weaning patients from acute dialysis and offer valuable insights into distinct AKI subgroups. The proposed management of AKI, which is encapsulated in a structured flowchart, bridges the gap between research and clinical practice. It streamlines the utilization of biomarkers and subphenotyping, promising a future in which AKI is swiftly identified and managed with unprecedented precision. Incorporating kidney biomarkers into strategies for early AKI detection and the initiation of AKI care bundles has proven to be more effective than using care bundles without these novel biomarkers. This comprehensive approach represents a significant stride toward precision medicine, enabling the identification of high-risk subphenotypes in patients with AKI.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0